Marker Therapeutics (MRKR) Market Capitalization (2010 - 2026)

Marker Therapeutics (MRKR) has reported Market Capitalization for 17 consecutive years, with $24.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 41.99% year-over-year to $24.5 million in Q2 2026; TTM through Jun 2026 was $24.5 million, a 41.99% increase from a year earlier, with the FY2025 full-year figure at $24.9 million, down 25.22% from the prior year.
• Market Capitalization was $24.5 million for Q2 2026 at Marker Therapeutics, up from $21.7 million in the prior quarter.
• Over five years, Market Capitalization peaked at $48.9 million in Q4 2023 and troughed at $6.2 million in Q1 2023.
• A 5-year average of $27.9 million and a median of $26.2 million in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization plunged 88.1% in 2022 and jumped 512.52% in 2024, its largest moves.
• Over 5 years, Market Capitalization stood at $22.7 million in 2022, then soared by 115.83% to $48.9 million in 2023, then plunged by 32.02% to $33.3 million in 2024, then slipped by 25.22% to $24.9 million in 2025, then slipped by 1.34% to $24.5 million in 2026.
• The last three Market Capitalization figures came in at $24.5 million (Q2 2026), $21.7 million (Q1 2026), and $24.9 million (Q4 2025), per Business Quant data.